NexGel, Inc. (NXGL)
0.2991
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 11:40
NexGel Shareholders Equity (Quarterly) : 4.949M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.949M |
| March 31, 2026 | 3.994M |
| December 31, 2025 | 4.459M |
| September 30, 2025 | 5.186M |
| June 30, 2025 | 4.671M |
| March 31, 2025 | 5.209M |
| December 31, 2024 | 5.755M |
| September 30, 2024 | 4.687M |
| June 30, 2024 | 4.167M |
| March 31, 2024 | 4.788M |
| December 31, 2023 | 4.697M |
| September 30, 2023 | 5.698M |
| June 30, 2023 | 6.181M |
| March 31, 2023 | 6.847M |
| December 31, 2022 | 7.637M |
| September 30, 2022 | 8.218M |
| Date | Value |
|---|---|
| June 30, 2022 | 9.348M |
| March 31, 2022 | 10.30M |
| December 31, 2021 | 12.08M |
| September 30, 2021 | 0.484M |
| June 30, 2021 | 0.269M |
| March 31, 2021 | 1.00M |
| December 31, 2020 | 0.071M |
| September 30, 2020 | 0.374M |
| June 30, 2020 | 0.441M |
| March 31, 2020 | 0.556M |
| December 31, 2019 | 0.38M |
| September 30, 2019 | 0.188M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.281M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| Align Technology, Inc. | 4.232B |
| AngioDynamics, Inc. | 170.82M |
| Accuray, Inc. | 41.70M |
| Alphatec Holdings, Inc. | 11.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.45M |
| Total Liabilities (Quarterly) | 20.98M |
| Debt to Equity Ratio | 1.507 |
| Current Ratio | 0.4273 |
| Net Debt Paydown Yield | -19.41% |